In this text module an expert examines the evolving role of GPRC5Ddirected bispecific antibodies in relapsedrefractory multiple myeloma with a focus on evidence supporting bispecific antibodies and emerging CAR Tcell therapies across the treatment continuum Learners will explore considerations for treatment selection and sequencing of GPRC5Ddirected therapy in the current treatment landscape emerging data for talquetamabbased strategies and factors that may influence outcomes following prior targeted therapy The activity also addresses practical approaches to GPRC5Ddirected bispecific antibody dosing toxicity prevention and management and patient counseling to support safe and effective integration of talquetamab into clinical practice
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
97% of listed courses are free
292 of a sample of 300 are free · 536 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Online course / module
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedSep 4, 2026
-
Last day to claim creditMar 4, 2027 5 months left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Optimizing Integration of Bispecific Antibody Therapy to Improve Clinical Outcomes in Patients With Multiple Myeloma
-
Clinical Care Options, LLC (dba Decera Clinical Education) Personalizing Bispecific Antibody Therapy for Your Patients With Multiple Myeloma: Clinical Fundamentals, Current Evidence, and Expert Strategies for Community HCPs
-
Clinical Care Options, LLC (dba Decera Clinical Education) Advances in Bispecific Antibody Therapy for Multiple Myeloma: Strategies to Personalize Treatment and Elevate Patient Outcomes
